Annual report pursuant to Section 13 and 15(d)

ORGANIZATION, NATURE OF BUSINESS, AND RISK AND UNCERTAINTIES (Details)

v3.24.0.1
ORGANIZATION, NATURE OF BUSINESS, AND RISK AND UNCERTAINTIES (Details) - USD ($)
12 Months Ended
Sep. 28, 2023
Dec. 31, 2023
Number of months cash and investments sufficient to fund operating and capital expenditure   12 months
Stratasys Ltd    
Payment received for reimbursement of expenses upon termination of merger agreement $ 10,000,000.0  
Termination fee receivable 10,000,000.0  
Gain (loss) on termination of merger agreement $ 0